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ABSTRACT
CD40-MEDIATED SIGNALING OF INTERLEUKIN-1P SYNTHESIS AND RESCUE 
FROM APOPTOSIS IN MONOCYTES: MODULATION BY IL-4 AND IL-10
by
Jonathan C. Poe
To date, the cellular mechanisms involved in the progression of diseases characterized 
by chronic inflammation, such as rheumatoid arthritis (RA), remain largely unknown. 
However, cell-to-cell contact interactions between CD4+ helper T (Th) cells and 
monocytes have been implicated in the induction and maintenance o f pro-inflammatory 
cytokine synthesis that is characteristic to the pathogenesis o f RA. One such cytokine 
produced during monocyte-Th cell contact is interleukin (IL)-ip, a mediator directly 
involved in the characteristic tissue destruction that occurs in the synovia of individuals 
with RA. Previous studies in our laboratories have shown that ligation of CD40 on 
monocytes with CD40 ligand (CD40L) present on activated Th cells induces monocyte 
IL-ip synthesis and rescues monocytes from apoptosis. These findings suggest a role 
for CD40 signaling o f monocyte activation in the exacerbation and maintenance of 
chronic inflammatory responses. This dissertation represents efforts to elucidate 
components of the CD40 signaling pathway critical to monocyte activation and how 
CD40-mediated signaling events are modulated by the anti-inflammatory cytokines IL-4 
and IL-10.
Using either monocytes isolated from human peripheral blood or a monocytic cell line 
(THP-1), cellular kinases and transcription factors activated upon CD40 ligation were 
examined by western blot analyses and electrophoretic mobility shift assays (EMSA), 
respectively. Also, how the specific inhibition of these proteins affects CD40-mediated 
IL-ip synthesis and rescue from apoptosis was investigated by SDS-PAGE and 
apoptosis assays, respectively. Finally, the ability o f IL-4 and IL-10 to downregulate 
these signaling events was examined by pre-treating monocytes with these cytokines 
prior to stimulation through CD40.
CD40-dependent interleukin-1 P synthesis in monocytes was abrogated by inhibitors o f  
protein tyrosine kinase (PTK) activity but not by inhibitors of protein kinase C (PKC). 
Also, stimulation o f monocytes through CD40 resulted in the rapid activation of 
Nuclear Factor-icB (NF-kB), an event reduced by the inhibition of PTK activity. In 
addition, both EL-4 and EL-10 decreased CD40-dependent EL-ip synthesis in a dose- 
dependent manner individually and synergized in this effect when used concurrently, 
with minimal effect on CD40 surface expression. Also, both IL-4 and EL-10
iii
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diminished CD40-mediated tyrosine phosphorylation of monocyte cellular proteins. 
However, IL-4, but not IL-10, blocked CD40-mediated rescue from apoptosis, an event 
which we have demonstrated previously to be dependent on PTK activity. The 
extracellular signal-regulated kinases 1 and 2 (Erkl/Erk2) mitogen-activated protein 
kinases (MAPK’s) were specifically activated upon CD40 ligation, and specific 
inhibition of Erkl/Erk2 activation diminished IL-ip production in a dose-dependent 
manner. Both IL-4 and IL-10 reduced Erkl/Erk2 activation and synergized in this 
effect. Finally, STAT3, a member o f the family of transcription factors involved in 
cytokine signaling, was highly phosphorylated in monocytes treated with IL-10 or with 
IL-10 and EL-4 in combination but not with EL-4 alone.
Together these results suggest that in monocytes 1) CD40-mediated EL-ip synthesis and 
NF-kB activation require PTK activity, 2) CD40-mediated IL-ip production is 
critically dependent upon Erkl/Erk2 activity, 3) both EL-4 and EL-10 target the 
Erkl/Erk2 signaling cascade in the downregulation of IL-ip synthesis, 4) IL-4 and EL­
IO have divergent effects on the CD40 signaling pathway in that these cytokines are 
synergistic with respect to their ability to inhibit CD40-mediated Erkl/Erk2 activation 
and EL-ip synthesis, and differ in their ability to block CD40-mediated rescue from 
apoptosis, and 5) STAT3 activation may be directly involved in the downregulatory 
effects o f EL-10 on CD40 signaling.
The elucidation of specific components involved in CD40 signaling of monocyte 
activation is important to the understanding o f how Th cell-monocyte interactions 
mediate chronic inflammation, in which CD40-mediated IL-ip synthesis and enhanced 
monocyte longevity may play a major role. Also, how these events can be modulated 
by natural mediators such as EL-4 and IL-10 will provide insight into which signaling 
proteins critical to CD40 signaling are candidates as targets for therapeutic intervention.
iv
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CHAPTER I
INTRODUCTION
Monocvte-Derived IL-lp in the Pathogenesis o f RA 
Antigen (Ag)-dependent monocyte/macrophage activation induced through 
interactions with helper (CD4+) T cells (Th cells) is an important component o f cell- 
mediated immune responses. However, monocyte activation driven by aberrant Th cell 
activation is implicated in the mediation o f  the characteristic tissue destruction that 
occurs in rheumatoid arthritis (RA), a debilitating autoimmune disease, and high numbers 
o f activated Th cells and monocytes are known to exist in the synovia o f  individuals with 
RA (Murphy and Reynolds 1993). Interleukin (IL)-ip production by activated monocytes 
is implicated in the pathogenesis o f RA, and is thought to be involved in both the onset 
and progression o f  disease (Wood and others 1985; Miller and Dinarello 1987; Miossec 
and others 1987). EL-ip production in RA stimulates rheumatoid synoviocytes to 
produce prostaglandin Eo (PGEj), an eicosanoid that induces RA-associated pain and 
edema. PGE2 in turn induces the production of interstitial collagenase (matrix 
metalloproteinase (MMP)-I) and type IV collagenase (MMP-4/gelatinase B) from these 
same cells (Mizel and others 1981; Dayer and others 1986, Corcoran and others 1992). 
Subsequently, interstitial collagenase and type IV collagenase, together with IL-ip, 
escalate the resorption o f cartilage and bone (respectively) in affected joints (Gowen and 
others 1983). Inevitable consequences o f such abnormal rates o f synovial tissue 
destruction are the characteristic joint deformity and dysfunction that occur during the
1
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2progression of RA.
Th Cell-Mediated Mbnocvte Activation Through the CD40L-CD40 Interaction
Monocyte activation during normal immune responses involves the initial antigen 
presentation event, where Th cells interact through the T cell receptor (TCR) with 
monocytes in an antigen-dependent, major histocompatibility complex type II (MHC-EQ- 
restricted fashion. Subsequent cell contact-mediated and cytokine-mediated signals result 
in reciprocal activation o f both the Th cell and the monocyte. Cell contact-mediated 
events involved in reciprocal Th cell-monocyte activation include interactions between 
pairs o f  adhesion molecules such as VLA-4:VCAM-1 and LFA-1:ICAM that facilitate 
prolonged cell contact, and between pairs of costimulatory molecules such as CD28:B7 
and CD40 ligand (CD40L):CD40. Signals for cellular activation derived through the 
formation of such conjugates between Th cells and monocytes are a vital component o f  
cell-mediated immune responses. These interactions are also likely to occur during 
chronic inflammatory responses such as in RA, resulting in the aberrant overproduction 
o f  pro-inflammatory cytokines such as EL-ip. In particular, recent studies strongly 
implicate Th cell-dependent activation o f monocytes through the CD40L:CD40 
interaction as a critical event in the onset and progression o f chronic, non-septic 
inflammation. (Note: CD40L has recently been assigned its own CD designation,
CD 154, but will be referred to as CD40L throughout this dissertation).
In early studies o f the interactions between Th cells and monocytes it was 
demonstrated that cell contact-mediated interactions are critical for monocyte activation
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
(Stout and Suttles 1992; Stout 1993; Suttles and others 1994). Critical activation signals 
could not be delivered by activated Th cell supernatants (cytokine contribution), or if  cell 
contact was prevented. However, key signals were generated by the incubation of 
monocytes/macrophages with activated, paraformaldehyde-fixed Th cells, thus indicating 
dependence upon direct cell contact (Stout and Suttles 1993). It has been demonstrated 
since that time that signaling through CD40 is alone sufficient to induce substantial 
inflammatory cytokine production by monocytes/macrophages (Wagner and others 1994, 
Stout and others 1996).
Description. Cellular Distribution, and Functions o f CD40 
CD40, a member of the tumor necrosis factor receptor superfamily, is a 
transmembrane glycoprotein of ~  45-kDa expressed by a number of cell types 
including B cells (Clark 1990), monocytes/macrophages (Alderson and others 1993; 
Wagner and others 1994), dendritic cells (Caux and others 1994), thymic epithelial cells 
(Galy and Spits 1992), and endothelial cells (Yellin and others 1995). CD40 signaling 
has been shown to induce functional changes on these cell types that may contribute to 
inflammatory responses, including cytokine production and the up-regulation of 
costimulatory and adhesion molecule expression (Stout and Suttles 1996). Signaling via 
CD40 is dependent upon the interaction with its natural ligand, CD40L, expressed by 
activated Th cells. In B cells, CD40 signaling provides critical costimulatory signals 
required for activation including proliferation and survival, isotype switching, germinal 
center formation, and the generation o f memory B cells (Grabstein and others 1993;
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
4Nonoyama and others 1993; Splawski and others 1993). Crosslinking o f CD40 by anti- 
CD40 monoclonal antibodies (mAbs) induces proliferation o f resting B cells, and 
treatment o f these cells with anti-CD40 or a CD40L fusion protein, in the presence o f  
cytokines including IL-4, IL-5 and EL-10 has been shown to induce antibody (Ab) 
production and isotype class switching (Grabstein and others 1993; Splawski and others 
1993; Banchereau and others 1994).
Circulating monocytes constitutively express CD40, and CD40 ligation has been 
shown to induce monocyte-derived inflammatory cytokine production (Wagner and 
others 1994), to induce nitric oxide production in macrophages (Tian and others 1995; 
Stout and others 1996), and to rescue monocytes from undergoing apoptosis 
(programmed cell death) induced by the deprivation of serum growth factors (Suttles 
and others 1996). The role of CD40 in macrophage activation has further been 
substantiated by the demonstration that activated Th cells from CD40L-knockout mice 
are deficient in their ability to induce macrophage effector function (Stout and others 
1996). In sum, studies thus far indicate that, at sites of chronic inflammation, activated 
T cells have the potential to activate resting monocytes in a contact-dependent, antigen- 
independent manner, solely through CD40 ligation. The result o f  this interaction is the 
production of inflammatory cytokines and enhanced monocyte viability, leading to 
maintenance (or augmentation) o f the inflammatory process. This scenario is 
particularly relevant to the pathogenesis of RA. In RA, initial Th activation occurs 
through autoantigen recognition, the nature of which currently remains unknown. These 
cells then home to synovial tissues (where monocytes are also present), and have the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5potential at this point to induce monocyte pro-inflammatory cytokine synthesis in an 
antigen-independent manner, solely through CD40 ligation.
Although the nature o f the CD40 signaling pathway in monocytes has not been 
elucidated, CD40 signaling in B cells has been shown to involve protein tyrosine kinase 
(PTK) activity, as well as the activity o f serine/threonine kinases (Uckun and others 
1991; Faris and others 1994). Signaling proteins reported to be activated through CD40 
in B cells include protein kinase C (PKC), the PTK’s lyn, fyn, and syk, Ras, 
phosphatidylinositol-3 (PI-3) kinase, and the c-Jun N-terminal kinase (JNK) member of 
the mitogen-activated protein kinase (MAPK) family (Faris and others 1994; Ren and 
others 1994; Sakata and others 1995; Gulbins and others 1996; Sutherland and others 
1996). The Ras proto-oncogene product is a ubiquitously expressed GTP-binding 
protein (G-protein) that is known to function in a linear cascade that leads to the 
activation of MAPK activity (Figure 1). Importantly, although CD40-mediated Ras 
activation in B cells has been shown to result in the activation o f MAPK/Erk kinase 1 
(MEK1) (Gulbins and others 1996), the extracellular signal-regulated protein kinases 1 
and 2 (Erkl and Erk2) MAPK’s, the only known MEK1 substrates, are not subsequently 
activated (Sakata and others 1995; Sutherland and others 1996). One possible 
explanation for this lack o f  Erk activation during CD40 signaling in B cells may be the 
activity o f Erk-directed phosphatases. JNK, the only member o f the MAPK family 
shown to be activated via CD40 signaling in B cells (Sakata and others 1995; Sutherland 
and others 1996), is known to be activated independently o f the Ras signaling cascade
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure 1. The Erkl/Erk2 MAPK and JNK MAPK Signaling Cascades
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(Cobb and Goldsmith 1995). Together these observations suggest that Ras-dependent 
MEK1 activation induced by CD40 ligation in B cells may be functionally insignificant, 
and that JNK is the member of the MAPK family involved in CD40-mediated B cell 
activation.
In our previous work we demonstrated that the pathway o f  monocyte CD40 
signaling resulting in rescue from apoptosis is critically dependent on the generation o f  
PTK activity and does not appear to involve activity o f the serine/threonine PKC family 
(Suttles and others 1996). Beyond this, however, components involved early in CD40 
signal transduction in monocytes, as well as downstream components involved in gene 
transcription, are yet to be elucidated. Nuclear Factor-kappa B (NF-kB) is a ubiquitous 
transcription factor involved in the transcription o f numerous genes in multiple cell types. 
I kappa B (IkB) family members are responsible for inhibiting NF-kB activation by 
sequestering NF-kB homodimers/heterodimers in the cytoplasm through binding o f the 
NF-kB rel homology domain, resulting in the concealment of the nuclear localization 
sequence (Ganchi and others 1992; Zabel and others 1993). Phosphorylation, followed 
by the ubiquitination and proteasomal degradation of IkB, allows active NF-kB to be 
rapidly translocated to the nucleus where it can bind relevant gene promoters (Beg and 
others 1993; Brown and others 1993; Cordle and others 1993; Henkel and others 1993; 
Mellitis and others 1993). Of particular importance is the involvement of NF-kB in the 
transcription of the genes for pro-inflammatory cytokines, including IL-lp. It has been 
demonstrated that following lipopolysaccharide (LPS) stimulation, IL-ip mRNA is 
rapidly transcribed (Fenton and others 1987), suggesting that preexisting transcription
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
8factors such as NF-kB are involved in transcription o f the IL-ip gene. The presence of 
binding elements for NF-kB, as well as for other transcription factors including NF- 
PA, AP-1, and NF-IL6, have been reported in the IL-lp gene promoter region (Fenton 
and others 1987). In B cells, CD40 signaling has been shown to result in the activation 
of NF-kB (Lalmanach-Girard and others 1993). However, because CD40-mediated 
activation of B cells generally involves signaling events that modulate antibody 
production, and not the induction o f pro-inflammatory cytokines, the nature of NF-kB 
activation as a downstream event o f CD40-mediated signaling events may be very 
different in monocytes.
IL-4 and EL-10 are modulatory cytokines that have been shown to exhibit anti­
inflammatory properties both in vivo and in vitro by directing Th populations toward a 
Th2-like (humoral/antibody-dependent immune response) cytokine production profile 
(Mosmann and Moore 1991; Sher and others 1991; Chatelain and others 1992; Maggi 
and others 1992; Sher and others 1992; Mocci and Coffman 1995). Thl-like (cell- 
mediated) responses, in contrast to Th2 responses, includes Th cell-dependent 
activation of monocytes and the subsequent production of pro-inflammatory cytokines, 
including IL-ip. The primary cellular source of IL-4 and EL-10 is the Th2 subset of 
helper T cells, although a major source of IL-10 is also the activated 
monocyte/macrophage. Direct effects of IL-4 and IL-10 on monocyte/macrophage 
function have been observed, including downregulation o f bacterial LPS-induced 
macrophage inflammatory cytokine production (Hart and others 1989; de Waal Malefyt 
and others 1991; Donnely and others 1990; te Velde and others 1990; Fiorentino and
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9others 1991), and inhibition of macrophage cytotoxic activity (Oswald and others 1992). 
In addition, EL-4 has been shown to counteract the rescue o f monocytes from, serum 
deprivation-induced apoptosis that is mediated through treatment with EL-1 and LPS 
(Mangan and others 1992). IL-10 has been shown to induce apoptosis in monocytes 
cultured in the absence of, but not in the presence of, granulocyte-macrophage colony- 
stimulating factor (GM-CSF) and interferon-y (IFN-y) (Bach and Brashler 1995), 
cytokines with potent monocyte/macrophage activating capacities.
To exert their effects, cytokines activate members o f the Janus kinase (Jak) family 
o f tyrosine kinases which subsequently activate members o f a family o f  transcription 
factors known as “signal transducers and activators o f transcription,” or STAT’s (Figure 
2). Upon cytokine receptor ligation and aggregation, one or more Jak kinases associate 
with a domain known as the “boxl/box2 motif' that is located within the membrane- 
proximal domain o f the signal-transducing chain(s) o f cytokine receptors. This 
association results in the activation o f Jak kinases through Jak transphosphorylation. In 
turn, activated Jak kinases phosphorylate the cytokine receptor at specific tyrosine 
residues which are recognized by a src homology 2 (SH2) domain located within the 
carboxy terminus o f STAT proteins. This localization o f  STAT proteins to the receptor 
allows for their subsequent tyrosine phosphorylation by a particular Jak kinase (Hou and 
others 1994; Heim and others 1995; Stahl and others 1995). STAT phosphorylation 
results in the formation o f STAT homo- or heterodimers (depending upon the STATs 
activated), followed by subsequent nuclear translocation and DNA binding o f related 
elements, inducing gene transcription. STAT transcription factors bind a nucleotide
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consensus motif o f TTNCNNNAA, and slight variations that exist in this sequence 
between specific genes dictates what STAT homo- heterodimers will preferentially bind 
(O’Shea 1997). Although IL-4 and IL-10 have similar effects on the downregulation o f  
LPS-induced monocyte activation, these cytokines utilize different Jak-STAT proteins 
during signal transduction. EL-4 receptor ligation results in the activation o f  STAT6 by 
Jak3, while IL-10 receptor ligation results in the activation o f  STAT1 and STAT3 by Jakl 
and Tyk2 (Ihle 1995; O’Shea 1997).
This dissertation represents the results of studies designed to evaluate the nature 
of kinase and transcription factor involvement in CD40 signaling of EL-ip production 
and rescue of monocytes from apoptosis and the effects of IL-4 and EL-10 on these 
CD40-mediated events. Peripheral blood monocytes or monocytic cell lines were 
stimulated either with an IgM anti-CD40 mAb that mimics the interaction o f  CD40 with 
CD40L, or with purified plasma membranes from resting Th cells (TmP) or from 6 h- 
activated Th cells (TmA) (which express high levels of CD40L), in the presence or 
absence of IL-4 and/or EL-10, or inhibitors o f cellular kinase activity. The activation of 
specific kinases and transcription factors that occurs upon CD40 ligation in monocytes, 
and how the activation states of these proteins (and their subsequent biologic effects) 
are modulated by cell treatment with IL-4, EL-10, and kinase inhibitors, was examined 
through a variety of experimental designs.
The elucidation of components involved in CD40 signaling of monocyte IL-ip 
synthesis, and how these events can be modulated by natural mediators such as IL-4 
and IL-10, will provide insight into potential targets for therapeutic intervention in the
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treatment of diseases that are characterized by chronic inflammation, such as RA.
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CHAPTER 2
MATERIALS AND METHODS
Control o f Endotoxin Contamination 
All cell culture reagents used were either certified as low endotoxin when 
purchased, or were ensured low endotoxin as determined by chromogenic limulus assay 
(BioWhittaker, Walkersville, MD). Stock solutions containing >1 ng/ml (10 EU/ml) 
were considered unacceptable. Stock solutions were diluted in assays such that endotoxin 
levels did not exceed 1 pg/ml.
Inhibitors
Herbimycin A and calphostin C were purchased from Calbiochem (La Jolla, CA). H7 
was purchased from Sigma Chemical Co. (St, Louis, MO). Sodium ortho vanadate 
(Na3V 04) was aquired from Fisher Scientific, (Fair Lawn, NJ). The MEK1/MEK2 
inhibitor PD98059 was obtained from New England Biolabs, Inc (Beverly, MA).
Antibodies fAbs')
Mouse IgM anti-human CD40 (BL-C4) (Monosan, the Netherlands) mAb was purchased 
from Caltag Laboratories (South San Francisco, CA). The IgM isotype control Ab was 
obtained from Southern Biotechnology Associates, Inc., (Birmingham, AL). The 
following mAb’s were prepared from culture supernatants of hybridomas purchased 
from American Type Culture Collection (ATCC, Rockville, MD): IgG mouse anti­
human EL-ip (H-6A), IgG mouse anti-human CD3 (OKT-3), IgG mouse anti-human
13
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CD8 (OKT-8), IgG mouse anti-human monocyte (3C10), IgG mouse anti-human B cell 
(LYM-1), IgM mouse anti-human NK cell (hNK-1), and IgG mouse anti-human CD40 
(G28-5). BioMag* goat anti-human IgG and IgM was obtained from PerSeptive 
Diagnostics, Inc. (Cambridge, MA). Horseradish peroxidase-conjugated anti- 
phosphotyrosine mAb (RC20) was purchased from Transduction Laboratories 
(Lexington, KY). FITC-conjugated donkey anti-mouse IgG (H +  L) was purchased 
from Jackson Immunoresearch Laboratories, Inc. (West Grove, PA). IgG mouse anti­
human CD40L mAb was obtained from Genzyme (Cambridge, MA). Rabbit anti-active 
(phospho-specific) MAPK polyclonal antibody (pAb) was aquired from Promega 
(Madison, WI). Rabbit anti-active (phospho-specific) STAT pAb was purchased from 
New England Biolabs, Inc.
Monocyte Isolation and Culture 
For IL-lp and kinase assays, blood was collected from normal, healthy human 
volunteers and PBMC's were isolated over a Ficoll density gradient (Fico-Lite- 
LymphoH, Atlanta Biologicals, Norcross, GA). PBMC's were plated at a density of 5 
x 106 cells/well in 24-well tissue culture plates (Falcon Primaria, Lincoln Park, NJ) in 
RPMI 1640 (Hyclone, Logan, UT), containing 100 mM HEPES, 50 /xg/ml gentamicin, 
and 5% FBS, henceforth referred to as R-5. Monocytes were isolated by plastic 
adherence for 1 h at 37 °C after which nonadherent cells were removed by Pasteur 
pipetting during 2 washes with Dulbecco's PBS (DPBS). Cells were maintained in R-5 
overnight prior to treatment.
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For apoptosis assays, elutriation-purified monocytes were used (cells provided 
by Dr. Larry M. Wahl, National Institutes o f Health, Bethesda, MD). The THP-1 
monocytic cell line was maintained in R-5 medium.
CD4H~ T Celi Purification and Activation 
CD4+ T cells were purified by negative magnetic panning from elutriation- 
enriched T cell populations (cells provided by Dr. Larry M. Wahl, National Institutes 
of Health, Bethesda, MD). Cells were incubated in R-5 with rnAb’s against cell 
surface molecules generated from the hybridomas OKT-8 (anti-CD8+ T cell), 3C10 
(anti-monocyte), LYM-1 (anti-B cell), and hNK-1 (anti-NK cell), used as culture 
supernatants at dilutions of 1:10, for 30 min at RT. Cells were then treated with 
BioMag* iron-conjugated antibodies to murine IgG and IgM (PerSeptives Diagnostics, 
Cambridge, MA) for 30 min with gentle shaking at 4 °C. Cells were diluted with 
DPBS in 75 cm2 flasks (Fisher Scientific) and the CD4" cells were removed via 27 
megagauss Oerstead magnets (PerSeptives Diagnostics). A sample of the purified 
population was stained with an FITC conjugated anti-CD4 mAb and analyzed by flow 
cytometry on a FACS* 420 flow cytometer (Becton Dickinson, San Jose, CA). The 
resulting population was typically found to be greater than 95% CD4+. CD4+ T cells 
were then rested in R-5 alone, or activated for 6 h in R-5 either by plating on anti-CD3 
(OKT-3)-coated tissue culture plates, or by incubation with 10 ng/ml PMA (Sigma) -+- 
0.5 jiiM ionomycin (Calbiochem, San Diego, CA). Expression of CD40L on activated, 
but not resting, CD4+ T cells was then confirmed by flow cytometric analysis on a
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FACS® 420 flow cytometer.
T-Cell Plasma Membrane Preparation 
Plasma membranes were prepared using a modification of the method o f Noelle 
and others (1991). Briefly, resting and activated elutriation-purified T cells were 
resuspended in a hypotonic buffer containing 50 mM Tris-HCL, pH 7.4, 25 mM KCI, 5 
mM MgCl2, and 50 fig/ml PMSF for 30 min on ice. The cells were then Dounce- 
homogenized until completely disrupted as determined microscopically. Disrupted cells 
were centrifuged at 500 x  g for 5 min to remove nuclei, then centrifuged at 95,000 x g for 
30 min using a Ti-50 rotor in a Beckman L5-65 Ultracentrifuge. Cell debris was 
resuspended in 35% (wt/vol) sucrose/hypotonic buffer then layered on 73% (wt/vol) 
sucrose/hypotonic buffer. Hypotonic buffer was layered on the 35% sucrose and the 
samples were centrifuged using a SW50.1 rotor at 130,000 x g for 1 h to separate plasma 
membranes. The plasma membrane layer (at the 73%-35% interface) was collected and 
diluted 1:5 with hypotonic buffer, then centrifuged again for lh at 130,000 x  g to pellet 
purified plasma membranes. The membrane pellets were resuspended in PBS and total 
protein was determined by microtiter plate protocol o f  the bicinchoninic acid protein 
assay (Pierce, Rockford, IL). The BCA protein assay was read on a Biotek Instruments 
microtiter plate reader at 561nm.
Metabolic Protein Labeling, rmmunoprecipitation of IL-lp. and SDS-PAGE 
IL-ip induction in monocytes by anti-CD40 was measured by metabolicaliy 
labeling the cells with 50 pCi/ml TranssS-Label™ (ICN Radiochemicals, Irvine, CA) in
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methionine-deficient RPMI 1640 (Hyclone, Logan, UT) supplemented with 5 jig/ml each 
insulin and transferrin (Sigma). After labeling, the culture medium was removed, cells 
were rinsed with DPBS and lysed in cold immunoprecipitation buffer containing 25 mM 
Tris-HCL pH 7.4, 1% Triton X-100, 1% deoxycholate, 0.35 MNaCl, 10 mM EDTA, and 
50 pg/ml PMSF. Lysates were immediately snap-frozen in a dry ice/ethanol bath.
Lysates were immunoprecipitated for IL-ip with mouse anti-human IL-ip followed by 
isolation with Immobilized rProtein-A™ (Repligen Corporation, Cambridge, MA). 
Precipitates were electrophoresed by SDS-PAGE on 15% minigels. The gels were 
prepared by methanol/glacial acetic acid fixation followed by gentle shaking in 
Autofluor™ (National Diagnostics, Atlanta, GA) for 45 min. Gels were then dried and 
exposed to Kodak X-Omat LS X-ray film (Eastman Kodak, Rochester, NY).
Electrophoretic Mobility Shift Assay HEMSA')
THP-1 ceils cultured in R-5 were transferred to 6-well tissue culture plates at a 
concentration o f 2.5x107 cells/well. After treatment or stimulation as required by the 
particular assay, cells were collected and lysed to isolate nuclei based on the method o f  
Buras and others (1994). Briefly, cells were lysed in hypotonic buffer containing 10 mM 
KC1, 0.3 M sucrose, 10 mM P-glycerol phosphate, 0.2 mM EDTA, 0.4% nonidet P-40, 1 
mM PMSF and 1 pg/ml each of leupeptin and pepstatin, on ice for 30min with 
intermittent gentle agitation. Following lysis, nuclei were collected by centrifugation at 
11,500 x g for 5min. Nuclear proteins were extracted by incubating nuclei in a buffer 
containing 25% glycerol, 0.3 M KC1, 1.5 mM MgCL 0.2 mM EDTA, 0.5 mM
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dithiothreitol, 1 mM PMSF, and 1 pg/ml each o f  leupeptin and pepstatin for 30 min on 
ice. Extracts were centrifuged at 11,500 x g and supernatants were collected as nuclear 
extracts. Extracts were concentrated and reconstituted to 0.1 M  KC1 using Microcon 
microconcentrators from Amicon (Beverly, MA). Protein determinations were performed 
by the BCA micro protein assay. Extracts were aliquoted and stored at -80° C.
Binding assays were performed using a consensus oligonucleotide containing the 
binding element for NF-kB (Promega Corp., Madison, WI) that was end-labeled using 
j2P-gamma ATP (ICN Biomedicals Inc., Irvine, CA). Nuclear extracts were incubated 
with gel shift binding buffer (4% glycerol, 1 mM MgCl2 0.5 mM EDTA, 0.5 mM DTT,
50 mM NaCl, 10 mM Tris, pH 7.5, 0.05 mg/ml salmon sperm DNA), and 32P- end- 
labeled oligonucleotide at approximately 5x105 cpm. Binding reactions were done at 
room temperature for 20 min. Cold competition assays were performed by first adding a 
40-fold concentration o f unlabeled NF-kB consensus oligonucleotide, incubating for 20 
min, then adding 32P-labeled oligonucleotide. Following binding reactions, samples were 
analyzed on 4%  polyacrylamide gels. Following electrophoresis, gels were dried onto 
Whatman filter paper and exposed to X-ray film from several hours to overnight at room 
temperature. Band densities were determined with a BIO Image® Whole Band Analyzer 
program (Millipore, Ann Arbor, MI) following autoradiograph scanning on a Scanmaster 
3+™ scanner (Howtek, Hudson, NH).
Western Blot Analysis 
Prior to stimulation, monocytes were pretreated with 50pM Na3V 0 4 for 20 min to
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negate PTP effects on tyrosine-phosphorylated cellular proteins during stimulation. After 
monocyte treatment/stimulation in 24-well plates, cells were lysed in 50 pi boiling 
treatment buffer (125 mM Tris, pH 6.8,2% SDS, 20% glycerol, 1% beta- 
mercaptoethanol, and 0.003% bromophenol blue) containing 1 mM each PMSF and 
sodium orthovanadate. Samples were boiled an additional 5 min prior to protein 
separation by SDS-PAGE on 15% minigels. Gels were equilibrated in transfer buffer (48 
mM Tris, pH 9.2, 39 mM glycine, 1.3 mM SDS, and 20% methanol) for 15 min prior to 
transfer. Protein transfer to nitrocellulose membranes (Coming Costar Corp.,
Kennebunk, ME) was performed at 15V for 30 min using a Trans-Blot® SD Semi-Dry 
Electrophoretic Transfer Cell (Bio-Rad, Richmond, CA). Dried membranes were blocked 
by gentle agitation in PBS containing 0.1% Tween 20 and 1% BSA (blocking buffer) for 
30 min at 37° C. Membranes were incubated with the relevant primary Ab in blocking 
buffer for 30 min at 37° C, and then washed for 10 min x2 washes in PBS containing 
0.1% Tween 20 (wash buffer), followed by incubation with the relevant (HRP- 
conjugated) secondary Ab for 30 min at 37°C (if the primary antibody was not HRP- 
conjugated), and then washed for 10 min x3 in wash buffer. Ab-bound proteins were 
detected using an ECL™ Western blotting analysis system (Amersham Corp., Arlington 
Heights, IL) and the membranes were exposed to Kodak X-Omat LS X-ray film (Eastman 
Kodak, Rochester, NY).
Analysis o f  CD40 Surface Expression 
Monocytes were harvested from tissue culture plates by brisk pipetting in cold
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
20
monocyte wash buffer (0.2% EDTA and 0.1% sodium azide in PBS). Monocytes were 
stained with a 1:10 dilution o f G28-5 (IgG anti-human CD40) for 30 min at room 
temperature, washed in DPBS, and stained with a FITC-conjugated donkey anti-mouse 
IgG (H + L) secondary Ab for 30 min at RT. Cells were washed in DPBS and analyzed 
for CD40 surface expression on a FACS® 420 flow cytometer (Becton Dickinson, San 
Jose, CA).
Analysis o f Monocvte Apoptosis 
Apoptosis was monitored by both agarose gel electrophoresis and flow cytometry. 
Elutriation-purified monocytes were incubated with or without stimulus at 2.5 x 106 per 
tube (polypropylene) in 500 pi serum free medium (RPM I1640, containing 100 mM 
HEPES and 50 pg/ml gentamicin, henceforth referred to as R-0). The cells were 
harvested after a 72 h incubation period. For gel electrophoresis the cells were pelleted 
and lysed in a buffer containing 10 mM EDTA, 50 mM Tris pH 8.0, 0.5% lauroyl 
sarkosinate, and 0.5 mg/ml protease K (reagents purchased from Sigma Chemical Co., 
St. Louis, MO). The samples were incubated for 1 h at 50 °C, then treated with 
RNAse A (100 pg/ml) for 1 h. The samples were heated to 65°C for 5 min and then 
analyzed on 1.2% agarose gels containing 0.5 pg/ml ethidium bromide. DNA 
laddering was visualized by UV light.
For flow cytometric assay of apoptosis, cells were harvested and labeled with 5 
pg/ml propidium iodide in PBS for 15 min at RT. Flow cytometric analysis was 
performed using a FACS 420® flow cytometer with fluorescence detected at 620 mn.
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CHAPTER 3
RESULTS
PTK Activity is a Requirement for CD40-Mediated Induction o f IL-1 p Synthesis in
Monocvtes
To determine the nature of kinase involvement in CD40 signaling in monocytes, 
CD40-mediated IL-ip production was evaluated in monocytes pre-treated with inhibitors 
of PTK and PKC activity. As stated above, both PTK activity and the activity o f the PKC 
family o f serine/threonine kinases has been demonstrated through CD40 signaling in B 
cells. Monocytes were treated either with herbimycin A, a potent, broad PTK inhibitor, 
or H-7, an inhibitor of PKC, prior to anti-CD40 stimulation. The inhibitors were used at 
concentrations based on previous reports, as well as experimentally, in that caution was 
exercised to ensure that the concentrations used did not affect cell viability and total 
protein synthesis. Pre-treatment of monocytes for 18 h with 0.2 fiM and 1.0 pM 
herbimycin A, but not at any o f the concentrations of H-7 tested, abrogated anti-CD40 
stimulation o f IL-1 P synthesis (Figure 3A). Interestingly, IL-ip synthesis was noted to be 
moderately increased in anti-CD40 stimulated cells treated with H-7. Neither herbimycin 
A or H-7 treatment alone induced IL-ip synthesis (data not shown). These results 
indicate a requirement for PTK activity, but not PKC activity, in CD40 signaling o f IL-1 P 
synthesis in monocytes.
We hypothesized that, since protein tyrosine phosphorylation does play a critical 
role in CD40-mediated monocyte activation, then inhibition of phosphotyrosine
21
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Figure 3. Requirement for PTK Activity in CD40-Induced IL-ip Synthesis. A, monocytes 
were preincubated for 18 h with various doses o f  herbimycin A or H-7, and stimulated 
with anti-CD40 for 4 h. Cell lysates were immunoprecipitated for EL-ip and analyzed by 
SDS-PAGE. Lane 1, unstimulated; lane 2, anti-CD40 alone; lanes 3-5, anti-CD40 + 0.02 
pM, 0.2 pM, and 1.0 pM herbimycin A, respectively; lanes 6-8, anti-CD40 + 2 pM, 4 
pM, and 8 pM H-7, respectively. B, monocytes were preincubated for 20 min with 
various doses o f  Na3V 0 4, and then stimulated with anti-CD40. Cell lysates were 
immunoprecipitated for EL-ip and analyzed by SDS-PAGE. Lane 1, unstimulated; lane 2, 
anti-CD40 alone; lanes 3-5, anti-CD40 +  10 pM, 50 pM, and 100 pM Na3V 0 4, 
respectively; lane 6, 50 pM Na3V04 alone. Each panel represents the results o f  one of  
two separate experiments performed with similar results.
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phosphatase (PTP) activity should enhance CD40-mediated IL-ip production due to 
maintenance o f the phosphorylated state o f  key proteins. To test this hypothesis, 
monocytes were pretreated with various doses o f the broad PTP inhibitor Na3V 04 for 20 
min prior to anti-CD40 stimulation for 4 h. A dose-dependent enhancement o f IL-1 (3 
synthesis was noted with increasing concentrations o f Na3V 0 4 compared to untreated 
monocytes stimulated with anti-CD40 (Figure 3B).
CD40 Signaling Induces the Rapid Activation o f NF-kB in Monocvtes. an Event 
Influenced bv CD40-Induced PTK Activity 
NF-kB is involved in the transcription o f the genes for pro-inflammatory 
cytokines, including IL-ip. Since CD40-mediated IL-ip synthesis requires PTK activity 
(Figure 3), we hypothesized that CD40-induced PTK activity may also be required for the 
activation o f  NF-kB. Therefore, the effects o f PTK inhibitors on TmA-induced NF-kB 
activation were examined. THP-1 monocytic cells were treated for various time intervals 
with TmA (with TmR serving as a control), and nuclear localization o f NF-kB was 
evaluated by EMSA as described in materials and methods. NF-kB was rapidly activated 
(at the 15min time interval) in THP-1 cells stimulated with 5 pg/ml TmA, and was 
maximal at ~  2 h, after which levels began to wane slowly as noted at the 3 h and 4 h 
activation periods (Figure 4). NF-kB activation was not observed in THP-1 cells treated 
with TmR for 2h. Based on the observation that CD40-dependent IL-ip synthesis in 
monocytes was abrogated by herbimycin A  treatment (above data), we hypothesized that 
these effects on IL-ip may be at least partially dependent upon the activation state o f  NF-
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Figure 4. Kinetics o f CD40-Mediated NF-kB Activation in THP-1 Monocytic Cells. 
THP-1 cells were stimulated with 5 jig/ml TmR or TmA for various time intervals. Cells 
were then lysed and nuclear proteins extracted, and an EMS A  was performed for NF-kB 
activation. Band densities were determined by scanning densitometry. Lane 1, 
unstimulated; lane 2 ,2  h TmR stimulation; lanes 3-8, 15 min, 30 min, 1 h, 2 h, 3 h, and 4 
h TmA stimulation, respectively; lane 9, cold competition assay o f  2h TmA stimulation. 
Data represents one o f two separate experiments that produced similar results.
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kB. To evaluate the effects o f PTK inhibitors on NF-kB activation in monocytes, THP-1 
monocytic cells were treated with pre-determined doses o f herbimycin A, genistein (also 
a broad PTK inhibitor), or H-7 for 18 h and then stimulated with TmA. A reduction in 
NF-kB activation was observed in TmA-stimulated cells pre-treated with herbimycin A  or 
genistein compared to untreated cells or cells pre-treated with H-7 in which, as was noted 
above for EL-ip synthesis, NF-kB activation was slightly increased (Figure 5).
The effect of inhibiting PTP activity was also examined in order to further 
evaluate the importance of the PTK pathway in CD40-mediated NF-kB activation. We 
hypothesized that because the inhibition of PTP activity augmented CD40-mediated EL- 
ip  synthesis, then CD40-mediated NF-kB activation would also be enhanced in cells 
treated with a PTP inhibitor if protein tyrosine phosphorylation does play a critical role 
in CD40-mediated monocyte activation due to maintenance of the phosphorylated state 
of key proteins. To test this hypothesis, THP-1 cells were pretreated with Na3V 0 4 for 20 
min prior to 2h TmA stimulation. Enhancement NF-kB activation was noted in THP-1 
cells treated with 50 pM and 100 pM concentrations of Na3V 0 4 compared to untreated 
cells (Figure 6).
CD40 Signaling Induces the Tyrosine Phosphorylation of Monocvte Cellular Proteins, an
Event Downregulated by IL-4 and IL-10 
Because o f the requirement for PTK activity in CD40-mediated IL-ip synthesis, 
the effect o f CD40 stimulation on overall levels o f tyrosine phosphorylation in monocytes 
was examined by western blot analysis o f  total protein using an anti-phosphotyrosine
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Figure 5. PTK Inhibitors Decrease CD40-Dependent NF-kB Activation in THP-1 Cells. 
THP-1 cells were pre-incubated for 18 h with or without herbimycin A, genistein, or H-7, 
and then stimulated with TmA for 2 h. Cells were lysed and nuclear proteins were 
extracted, and an EMSA was performed for NF-kB activation. Band densities were 
determined by scanning densitometry. Lane 1, TmR; lane 2, TmA alone; lane 3, TmA + 0.2 
pM herbimycin A; lane 4, TmA +  0.4 pM genistein; lane 5, TmA + 4 pM H-7. Data 
represents one o f  two separate experiments that produced similar results.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
27
120
100
Figure 6. Na3V 0 4 Enhances CD40-Dependent NF-kB Activation in THP-1 Cells. THP-1 
cells were pre-incubated for 20 min with or without various doses o f Na3V 0 4. Cells were 
then stimulated with TmA for 2 h, followed by lysis o f  cells, extraction o f  nuclear proteins, 
and EMSA for NF-kB activation. Band densities were determined by scanning 
densitometry. Lane 1, TmR; lane 2, Tnt  ^alone; lanes 3-5, TmA +  10 pM, 50 pM, and 100 
pMNa3V 0 4, respectively; lane 6, 100 pM Na3V 0 4 alone. Data represents one o f  two 
separate experiments that produced similar results.
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mAb. Enhancement of overall levels of tyrosine phosphorylation of cellular proteins 
was apparent in. monocytes treated with either anti-CD40 (Figure 7, Part A, lane 2), or 
TmA, representing the natural ligand (Figure 7, Part A, lane 5). The enhanced 
phosphorylation was particularly evident on a dominant protein of ~ 68-kDa (indicated 
by arrows). Analysis o f CD40-mediated tyrosine phosphorylation was performed at 
various time intervals ranging from 10 min to 1 h, and the protein described above 
remained the major tyrosine phosphorylated protein at all time points (data not shown). 
It has been previously demonstrated that at 6 h post activation of T cells, the time point 
at which TmA are prepared, CD40L dominates the monocyte/macrophage-activating 
capacity of these cells (Wagner and others 1994; Stout and others 1996; Suttles and 
others 1996). Importantly, the ability of Tnf*1 to enhance tyrosine phosphorylation was 
blocked by the addition of a neutralizing anti-CD40L mAb (Figure 7, Part A, lane 6), 
again implicating the CD40-CD40L interaction as the primary receptor-ligand pair 
involved in T cell stimulation o f monocytes. Since we demonstrated that PTK activity is 
required for CD40-dependent signaling of EL-10 synthesis, we investigated whether IL- 
4 and IL-10, cytokines that downregulate LPS-mediated monocyte activation, influence 
anti-CD40-induced tyrosine phosphorylation. Monocytes were preincubated for 18 h in 
the presence or absence of IL-4 and/or IL-10 and then stimulated with anti-CD40, and 
tyrosine phosphorylation of cellular proteins was evaluated by western blot. Pre­
treatment of monocytes for 18 h with either EL-4 and/or EL-10 reduced anti-CD40 
induced tyrosine phosphorylation of cellular proteins to near basal levels (Figure 7, Part 
B). In a separate set of experiments performed as controls, we observed that
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Figure 7. CD40-Induced Tyrosine Phosphorylation o f  Monocyte Cellular Proteins, and 
Downregulation by IL-4 and IL-10. A, monocytes were stimulated with 5 pg/ml anti- 
CD40, an IgM isotype control, TmR, TmA, or TmA + anti-CD40L for 30 min. Cell lysates 
were harvested, proteins separated by SDS-PAGE, and a western blot performed for total 
tyrosine phosphorylation. Lane 1, unstimulated; lane 2, anti-CD40; lane 3, IgM isotype 
control; lane 4, TmR; lane 5, TmA; lane 6, TmA + anti-CD40L. B, monocytes were 
preincubated for 18 h at with 10 ng/ml IL-4 or IL-10, or 5 ng/ml each IL-4 and IL-10, and 
then stimulated for 30 min with anti-CD40. Cell lysates were harvested and proteins 
analyzed by western blot for total tyrosine phosphorylation. Lane 1, unstimulated; lane 2, 
2.5 gg/ml anti-CD40; lane 3, 5 pg/ml anti-CD40; lane 4, 5 pg/ml anti-CD40 +  10 ng/ml 
IL-4; lane 5, 5 pg/ml anti-CD40 +10 ng/ml IL-10; lane 6, 5 pg/ml anti-CD40 +  5 ng/ml 
each IL-4 and IL-10. Each panel represents one o f  three separate experiments performed 
that produced similar results.
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herbimycin A, but not H-7 or calphostin C (also a PKC inhibitor), abrogated CD40- 
induced tyrosine phosphorylation o f monocyte cellular proteins (data not shown).
IL-4 and IL-10 Downregulate CD40-Mediated IL-1 ft Synthesis in a Dose-Dependent
Manner, and Svnergize in this Effect 
To evaluate the potential modulatory effects o f IL-4 and EL-10 on CD40-mediated 
inflammatory cytokine production, monocytes were incubated in the presence or absence 
o f various doses o f  EL-4 or IL-10 for 18 h and then stimulated with anti-CD40 or TmA. 
Compared to untreated monocytes stimulated with anti-CD40, a potent, dose-dependent 
downregulation in EL-ip synthesis was observed for cells pretreated with IL-4 (Figure 8, 
Part A) or IL-10 (Figure 8, Part B). Also, EL-4 and IL-10 synergize in this effect, as 
shown by the complete abrogation o f  IL-1 P synthesis with use o f these cytokines together 
at either 5 ng/ml or 2.5 ng/ml each, compared to the reduction o f EL-ip when used 
individually at 10 ng/ml to pre-treat TmA-stimulated cells (Figure 8, Part C).
Additionally, we have observed that monocyte morphology, degree o f adherence to tissue 
culture plates, and ability to carry out de novo protein synthesis are generally unaffected 
after the time period o f  incubation with IL-4 and/or IL-10, even at the highest 
concentrations used, indicating that the downregulatory effects observed on EL-ip are not 
due to decreased cell viability (data not shown).
We considered the possibility that the downregulatory effects o f IL-4 and EL-10 on 
CD40-mediated IL-ip synthesis were due to a decrease in CD40 cell surface density, 
which could prevent anti-CD40 crosslinking and subsequent signal transduction. To
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Figure 8. Effects o f  EL-4 and IL-10 on CD40-Mediated EL-ip Induction in Monocytes. 
(A) and (B) Monocytes were preincubated for 18 h with, various doses o f IL-4 (A) or EL­
IO (B), and then stimulated with anti-CD40. Cell lysates were immunoprecipitated for EL- 
ip  and analyzed by SDS-PAGE. Lane 1, unstim; lane 2, anti-CD40 alone; lanes 3-7, anti- 
CD40 + 2.5 ng/ml, 5 ng/ml, 10 ng/ml, 50 ng/ml, and 100 ng/ml o f cytokine, respectively. 
(C) Monocytes were preincubated with IL-4, EL-10, or IL-4 + IL-10, and then stimulated 
with TmA for 4 h. Lane 1, TmA alone; lane 2, TmA +  10 ng/ml EL-4; lane 3, TmA + 10 
ng/ml EL-10; lane 4, TmA + 5 ng/ml each EL-4 and IL-10; lane 5, TmA + 2.5 ng/ml each EL- 
4 and EL-10. Data in each panel represents one o f  three separate experiments performed 
that produced similar results.
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examine the effects o f  EL-4 and DL-10 on CD40 cell surface expression, monocytes were 
preincubated with or without 10 ng/ml IL-4 or IL-10, or 5 ng/ml IL-4 +  IL-10, for 18 h 
and analyzed for the level o f CD40 surface expression by flow cytometry (Figure 9, Part 
A). CD40 labeling o f  IL-4 treated cells (mean fluorescence intensity, MFI, 58.3) showed 
a 20% reduction in CD40 expression as compared to untreated cells (MFI, 72.8). A  37% 
reduction in CD40 expression was observed on monocytes treated with IL-10 (MFI, 45.6) 
and a 40% reduction in CD40 expression was observed when monocytes were treated 
with both cytokines (MFI, 43.7). Although IL-4 and IL-10 treatment reduced CD40 
surface expression by as much as 40%, the level o f CD40 expression remaining was 
nearly 3-fold above background (MFI, 15). To confirm that the downregulatory effects o f  
IL-4 and IL-10 occur primarily at the level of the CD40 signaling pathway, monocytes 
were either treated with IL-4 and/or EL-10 during an 18 h pre-incubation period, or only 
upon the addition o f anti-CD40 (when normal levels o f  surface CD40 are present), and 
downregulation of IL-1 (3 synthesis was examined. Both IL-4 and IL-10 downregulated 
IL-1 P synthesis during co-incubation with anti-CD40 compared to untreated cells, 
although this reduction was less dramatic than observed with IL-4 and IL-10 pre­
treatment (Figure 9, Part B). The effect o f the addition of the cytokines only during the 
period o f anti-CD40 stimulation was particularly evident in monocytes coincubated with 
IL-4 + IL-10, where the reduction in EL-ip synthesis was >50% in repeated experiments.
IL-4. but not IL-10. Blocks CD40-Mediated Rescue of Monocytes from Apoptosis 
We next examined the effects o f IL-4 and IL-10 on CD40-mediated rescue of monocytes
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Figure 9. IL-4 and EL-10 Effects on CD40 Surface Expression and IL-lp Synthesis when 
Added only during Monocyte Stimulation. A, monocytes were preincubated for 18 h with 
10 ng/ml IL-4 (top panel), 10 ng/ml IL-10 (middle panel), or 5 ng/ml each IL-4 and IL-10 
(bottom panel). Cells were harvested, stained for surface CD40, and analyzed by flow 
cytometric analysis. B, monocytes were preincubated for 18 h with or without 10 ng/ml 
IL-4 or EL-10, or 5 ng/ml IL-4 +  IL-10. Cells were then stimulated for 4 h with anti- 
CD40 in the presence o f  the same concentrations o f  IL-4 and/or IL-10 added additionally 
to pretreated monocytes, or added to previously untreated cells. Cell lysates were 
immunoprecipitated for IL-ip and analyzed by SDS-PAGE. Lane 1, anti-CD40 alone; 
lanes 2-4, anti-CD40 + IL-4, IL-10, and IL-4/IL-10 preincubation, respectively; lanes 5-7, 
EL-4, EL-10, and EL-4/IL-10 treatment, respectively, only during anti-CD40 stimulation.
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from apoptosis induced by serum deprivation. We reasoned that since a previous study 
from our laboratory demonstrated that CD40-mediated rescue o f  monocytes from 
apoptosis was dependent upon PTK activity (Suttles and others 1996), EL-4 and/or IL-10 
may block the rescue event. Monocytes were incubated for 72 h in R-0 medium in the 
presence or absence o f  TmR or TmA, with or without 10 ng/ml IL-4 and/or IL-10. Cells 
were then harvested and analyzed for degree o f apoptotic cell death by agarose gel 
electrophoresis o f fragmented DNA, or by flow cytometric analysis of propidium iodide 
uptake. Apoptosis by agarose gel electrophoresis is evidenced by characteristic DNA 
“laddering” of multiples o f —200 bp (oligonucleosome-sized) fragments, and is shown 
flow cytometrically by increased uptake o f propidium iodide and decreased cell size. 
Interestingly, EL-4, but not IL-10, blocked CD40-mediated rescue of monocytes from 
apoptosis (Figures 10 and 11). Additionally, the effect o f IL-4 and IL-10 coincubation on 
rescue from apoptosis was unchanged from that o f treatment with IL-4 alone (Figure 11).
CD40-Med?ated IL-ip Synthesis is Dependent Upon Erk MAPK Activity 
To determine which specific kinases are involved in signal transduction in the 
CD40 signaling pathway in monocytes, a panel o f kinases whose activation states are 
dependent upon the phosphorylation o f tyrosine residues and which are possible 
candidates for CD40-mediated signaling were examined. O f the panel o f kinases 
evaluated, it was determined that CD40 signaling is critically dependent upon the 
activation o f the Erkl/Erk2 MAPKs. This is in contrast to previous observations in B 
cells in which JNK, but not Erkl/Erk2, mediates signaling through CD40 that is
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Figure 10. IL-4 and EL-10 Effects on CD40-Mediated Rescue of Monocytes from 
Apoptosis as Examined by Agarose Gel Electrophoresis. Monocytes were incubated in 
R-0 in the presence o f  TmR, TmA, TmA +  10 ng/ml EL-4, or TmA + 10 ng/ml EL-10 for 72 
h. Cells were harvested and analyzed for degree of apoptosis by separation of DNA 
fragments by agarose gel electrophoresis. Lane 1, unstim; lane 2, TmR; lane 3, TmA; lane 
4, TmA + IL-4; lane 5, TmA + IL-10. Data represents one o f three separate experiments 
performed that produced similar results.
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Figure 11. EL-4 and IL-10 Effects on CD40-Mediated Rescue o f Monocytes from 
Apoptosis as Examined by Flow Cytometric Analysis. Monocytes were incubated in R-0 
in the presence o f  TmR, TmA, TmA + 10 ng/ml IL-4, or TmA + 10 ng/ml IL-10 for 72 h. 
Cells were harvested and analyzed for degree o f  apoptosis by flow cytometry, with 
forward scatter (cell size) represented on the X-axis, and fluorescence (propidium iodide 
uptake) represented on the Y-axis. Results each represent one o f two separate 
experiments performed with similar results.
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dependent upon MAPK activity (Sakata and others 1995; Sutherland and others 1996). 
Although they belong to the family o f  MAPK’s, Erkl/Erk2 and JNK are activated by 
distinct mechanisms (Figure 1). Treatment o f monocytes with TmA, but not TmR, resulted 
in the rapid, dramatic activation of both Erkl and Erk2 (Figure 12), as observed by 
western blot using an anti-active Erkl/Erk2 MAPK pAb that specifically recognizes the 
dually phosphorylated (Thr and Tyr in the catalytic core) forms o f  Erkl and Erk2. 
Importantly, pre-treatment o f TmA with anti-CD40L mAb, but not with an isotype- 
matched control mAb, greatly reduced CD40-dependent Erkl/Erk2 activation, 
demonstrating again that CD40L is the primary monocyte-activating component of TmA.
To confirm that CD40-mediated EL-ip induction is dependent upon Erkl/Erk2 
activity, monocytes were pre-treated with the highly-specific MEK1/MEK2 inhibitor 
PD98059 prior to TmA stimulation o f monocyte IL-ip synthesis. Because Erkl and Erk2 
are specifically activated by, and are the only known substrates for, MEK1 and MEK2, 
the downregulation o f IL-ip production with the use o f this inhibitor would confirm the 
requirement for Erkl and Erk2 in CD40 signal transduction. To ensure that the 
MEK1/MEK2 inhibitor was used at concentrations that effectively diminish Erkl/Erk2 
activation in our system, monocytes were pre-treated with this reagent at dose ranges 
recommended by the manufacturer and then stimulated with TmA, and western blots were 
performed to evaluate effects on Erkl/Erk2 activation. Use o f the inhibitor at the 
recommended doses effectively inhibited Erkl/Erk2 activation (Figure 13, Part A). 
Importantly, PD98059 had no adverse effects on cell viability at the concentrations used, 
even during prolonged periods of treatment, as confirmed by examining total de novo
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Figure 12. CD40-Dependent Signaling of Erkl/Erk2 MAPK Activation in Monocytes. 
Monocytes were treated for 20 min with TmR, or with TmA in the presence or absence of 
anti-CD40L or isotype control antibodies. Cell lysates were harvested, proteins were 
separated by SDS-PAGE, and a western blot performed for Erkl/Erk2 activation. The 
membrane was then stripped and reprobed with anti-(3-actin. Lane 1, unstim.; lane 2, 
TmR; lane 3, TmA alone; lane 4, TmA +■ anti-CD40L; lane 5, TmA + isotype control. 
Results represent one of four separate experiments performed that produced similar 
results.
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Figure 13. Requirement for Erkl/Erk2 MAPK Activity for CD40 Signaling of IL-lp 
Synthesis in Monocytes. (A) Monocytes were pre-incubated for 1 h in the presence or 
absence of the MEK1/MEK2 inhibitor PD98059, and then stimulated with TmA for 20 
min. Erkl/Erk2 activation was then evaluated by western blot as described above. Lane 
1, unstim; lane 2, TmA alone; lane 3, TmA + 30 pM PD98059. (B) Monocytes were pre- 
incubated for 1 h in the presence or absence o f various doses o f PD98059, and then 
stimulated with TmA for 4 h during metabolic protein labeling. Cell lysates were 
harvested and immunoprecipitated for IL-ip as described in materials and methods. Lane 
1, unstim.; lane 2, TmA; lane 3, TmA + 1 pM PD98059; lane 4, TmA + 5 pM PD98059; 
lane 5, TmA +  30 pM PD98059. Each panel represents one of three separate experiments 
performed that produced similar results.
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protein synthesis after metabolic labeling o f cells with radioactive amino acids. Also, 
monocyte morphology and degree of adherence to tissue culture plates were unaffected by 
the inhibitor (data not shown). Pre-treatment o f monocytes with the MEK1/MEK2 
inhibitor effectively blocked CD40-mediated IL-ip induction, and this inhibition 
occurred in a dose-dependent manner (Figure 13, Part B), confirming the requirement for 
Erkl/Erk2 activity.
IL-4 and IL-10 Downregulate CD40-Mediated Erk MAPK Activation Individually and 
Svnergize in this Effect When Used Concurrently 
Because it was confirmed from experiments described above that Erkl/Erk2 
MAPK activity is critical to CD40-dependent IL-ip synthesis, we hypothesized that the 
downregulatory effects o f  EL-4 and IL-10 on CD40 signaling may occur through the 
inhibition o f Erkl/Erk2 phosphorylation. Additionally, we hypothesized that the 
synergistic effects o f IL-4 and IL-10 observed on IL-ip production may occur as a direct 
result of synergy in the inhibition of Erkl/Erk2 activation. Monocytes were pre-treated 
with IL-4 or IL-10 alone, or in combination at reduced doses, followed by TmA 
stimulation. IL-4 and IL-10 each reduced Erkl/Erk2 activation when used individually, 
and the inhibition o f Erkl/Erk2 activation was dramatically enhanced when the cytokines 
were used in combination (Figure 14).
Differential Activation o f  Members of the Jak-STAT Family o f  Signaling Proteins bv IL- 
4 and IL-10 in the Downregulation of CD40 Signaling 
IL-4 and IL-10, like other cytokines, exert their effects by utilizing members of the
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Figure 14. EL-4 and EL-10 Effects on CD40-Mediated Erkl/Erk2 Activation. Monocytes 
were pre-incubated for 18 h in the presence or absence o f  EL-4 and/or IL-10, followed by 
stimulation with TmA for 20 min. Cell lysates were harvested and analyzed by western 
blot for Erkl/Erk2 activation. The membrane was then stripped and reprobed with anti-P- 
actin. Lane 1, TmR; lane 2, TmA; lane 3, TmA + 10 ng/ml IL-4; lane 4, TmA + 10 ng/ml IL- 
10; lane 5, TmA + 5 ng/ml each IL-4 and IL-10. Results represent one o f three separate 
experiments performed that produced similar results.
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Jak-STAT family o f signaling molecules (Figure 2). The fact that both IL-4 and EL-10 
downregulate IL-ip production through CD40 signaling indicates that these cytokines 
induce Jak-STAT signaling cascades that mediate similar downstream functions. 
However, the data described above also suggest that the downstream events mediated by 
these cytokines are not identical. Rather, as is the case with IL-1(3 synthesis and MAPK 
activation, the function o f  one cytokine augments the function of the other in 
downregulatory activity. In addition, the fact that EL-4, but not EL-10, blocks CD40- 
mediated rescue o f  monocytes from apoptosis further supports the hypothesis that these 
cytokines affect the monocyte CD40 signaling pathway in a distinct manner. A likely 
mechanism for the disparate actions of IL-4 and EL-10 on CD40 signaling is the 
utilization o f  different Jak kinases/STAT transcription factors characteristic o f these 
cytokines (described above). In preliminary studies, we evaluated the possible role o f  
STATS activation by IL-10 in the downregulatory action of this cytokine on CD40- 
dependent signaling. This was made possible by the commercial availability o f an Ab 
that is specific for the activated form o f STAT3. As stated above, IL-10-mediated 
responses are believed to involve the activation o f STAT1 and STAT3 by Jakl and Tyk2. 
However, whether STAT3 activation is maintained for the duration o f the incubation 
period with which we observe maximal IL-10 downregulatory actions (18 h) through 
CD40 signaling in monocytes is unknown. Also, whether the synergistic effects o f IL-4 
in combination with IL-10 described above occur as a result o f an augmentation ofEL-10- 
mediated STAT3 activation by IL-4 remains to be elucidated. Therefore, the effects o f  
the pre-incubation of monocytes with IL-10 and EL-4 prior to stimulation through CD40
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on STAT3 activation was evaluated (Figure 15). Pre-treatment o f monocytes with IL-10, 
but not IL-4, resulted in a strong activation of STAT3. Also, STAT3 activation was 
maintained in monocytes treated with a combination o f IL-10 and EL-4, where each 
cytokine was used at one-half the dose o f that when used individually. Additionally, a 
slight activation o f STAT3 was observed in monocytes treated with TmA alone.
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Figure 15. IL-4 and IL-10 Effects on CD40-Mediated STAT3 Activation in Monocytes. 
Monocytes were pre-incubated for 18 h in the presence or absence o f  EL-4 and/or IL-10, 
followed by stimulation with TmA for 20 min. Cell lysates were harvested and analyzed 
by western blot for STAT3 activation. The membrane was then stripped and reprobed 
with anti-P-actin. Lane 1, TmR; lane 2, TmA; lane 3, TmA + 10  ng/ml EL-4; lane 4, TmA +  
10 ng/ml IL-10; lane 5, TmA + 5 ng/ml each IL-4 and IL-10.
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CHAPTER 4
DISCUSSION
The CD40L-CD40 interaction is critical in early cell contact-dependent signaling 
of monocyte/macrophage activation by Th cells in normal cell-mediated immune 
responses (Alderson and others 1993; Wagner and others 1994; Tian and others 1995; 
Stout and others 1996; Stout and Suttles 1996; Suttles and others 1996). During 
episodes of autoimmune inflammation, self-antigen-responsive Th cells recruited to an 
inflammatory site have the potential, once activated, to in turn activate resting 
monocytes solely through CD40 ligation, and thus independently of direct antigen 
presentation by the target monocyte. CD40 engagement on resting monocytes in the 
synovia of an individual with rheumatoid arthritis would induce IL-ip synthesis 
(Alderson and others 1993; Wagner and others 1994; Stout and others 1996), leading to 
sustainment or exacerbation of the inflammatory response, eventually resulting in 
localized tissue destruction. The presence o f IL-lp would also likely induce the 
maintenance of homing receptor and adhesion molecule expression in affected synovial 
tissues, allowing further infiltration of leukocytes to these sites.
Experiments described in this dissertation were performed to determine the 
nature of the CD40 signaling pathway in monocytes that results in activation of IL-ip 
synthesis and rescue from apoptosis, and the means by which these CD40-mediated 
events are modified by IL-4 and IL-10, cytokines with anti-inflammatory function (see 
also Poe and others 1997). Treatment of monocytes with either anti-CD40 or TmA
45
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resulted in the activation of NF-kB, an increase in overall tyrosine phosphorylation o f  
cellular proteins, and in the striking activation of the Erkl and Erk2 MAPK’s. The 
increase in tyrosine phosphorylation is functionally relevant as evidenced by the 
observations that 1) inhibitors of cellular PTK activity blocked CD40 stimulation o f IL- 
ip synthesis and reduced NF-kB activation and 2) treatment with N%V04, an inhibitor 
of PTP activity, enhanced CD40-mediated stimulation o f IL-P synthesis and NF-kB 
activation (Figures 3-6). Inhibition of PKC activity did not reduce these signaling 
events. Also, it was observed that the activation of the Erk MAPK’s is critical to CD40 
signaling in that the specific inhibition of MEK1 and MEK2, kinases that directly 
activate Erkl and Erk2, abrogated IL-ip synthesis induced by Tm*" stimulation (Figure 
13). Furthermore, the induction of PTK activity and of Erkl/Erk2 MAPK activity by 
TmA stimulation was confirmed to be dependent upon CD40L, in that pre-treatment of  
TmA with anti-CD40L neutralizing antibodies reduced both PTK (Figure 7) and 
Erkl/Erk2 (Figure 12) activation.
The critical dependence of CD40-mediated IL-lp synthesis on Erkl/Erk2 
activity is an important observation since in previous reports it was demonstrated that 
CD40 signaling in B cells does not induce Erk activation. Rather, CD40 signaling in B 
cells has been shown to activate JNK, a distinct member o f the MAPK family that is 
activated independently o f MEK1 and MEK2, the kinases that activate Erkl and Erk2 
(Figure 1). This suggests that CD40 signaling events specific to monocytes, such as the 
induction of pro-inflammatory cytokine synthesis, occur through the utilization of 
signaling mechanisms that are distinct from those utilized by the CD40 signaling
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pathway in other cell types. Although Erkl/Erk2 activation by MEK1/MEK2 in most 
signaling pathways studied (that utilize MAPK’s) has been shown to be dependent upon 
the Ras-raf signaling cascade, we have observed that CD40 signaling in monocytes does 
not induce Ras activation (data not shown). This observation is in contrast to LPS 
signaling in monocytes which has been shown to induce raf activation, directly 
implicating Ras involvement (Reinmann and others 1994). Furthermore, our data 
suggests that the CD40 signaling pathway in monocytes differs significantly from that 
of LPS in that LPS-mediated signaling of IL-ip and TNFa production in monocytes has 
been shown to be abrogated by inhibitors of PKC activity (Shapira and others 1994), 
indicating a requirement for PKC activity in LPS-mediated inflammatory cytokine 
induction. Despite the apparent differences between the signaling pathways employed 
by LPS and CD40, in both cases IL-4 and IL-10 are effective as inhibitors of 
inflammatory cytokine production induced by these pathways. The inhibitory effects o f  
these cytokines are unlikely to be at the level CD40 surface expression in that, although 
IL-4 and IL-10 reduced the level o f monocyte CD40 expression, the level of CD40 
expression remained nearly 3-fold above background and addition o f the cytokines at 
the onset of a 4 h anti-CD40 stimulation of monocytes reduced IL-lp production 
(Figure 9). Also, the fact that EL-4 and IL-10 synergize in the downregulation of 
Erkl/Erk2 MAPK activation (Figure 14) and IL-ip synthesis (Figure 13), but only 
decrease CD40 surface expression slightly more than that of IL-10 treatment alone, 
suggests that this decrease in expression is unlikely to be a major factor in the observed 
effects o f IL-4 and IL-10 on CD40 responsiveness. Finally, IL-10 does not prevent the
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rescue of monocytes from apoptosis by Tm* stimulation (Figures 10, 11), indicating 
that CD40 expression levels remain adequate for signal transduction to occur in IL-10- 
treated cells.
Two previous studies that evaluated the mechanisms o f IL-4 and EL-10 
downregulation o f LPS-induced pro-inflammatory cytokine synthesis suggested that EL- 
4 and EL-10 act by altering LPS-induced cytokine message stability (Wang and others 
1995; Takeshita and others 1996). However, although EL-4 and EL-10 were found to 
differentially affect inflammatory cytokine mRNA stability in monocytes or monocytic 
cell lines stimulated with LPS, the results of these two studies are somewhat 
conflicting. In one study EL-4, but not EL-10, was shown to decrease inflammatory 
cytokine message stability, including the pro-inflammatory cytokine EL-6, in LPS- 
stimulated monocytes (Wang and others 1995). In a separate study, it was observed 
that EL-6 mRNA degradation is enhanced by EL-10, but not EL-4, in LPS-stimulated 
monocytic cell lines (Takeshita and others 1996). Our data suggest, however, that IL-4 
and IL-10 may act at the same point, as well as at distinct points, in the CD40 signaling 
pathway. This is shown first by the fact that both cytokines similarly reduce CD40- 
associated PTK activity (Figure 7B) and levels o f EL-1 P synthesis (Figure 8A and B), 
suggesting overlapping effects of these cytokines. However, our data also suggest that 
EL-4 and IL-10 have divergent effects on monocyte CD40 signaling in that 1) these 
cytokines synergize in the downregulation of Erkl/Erk2 activation (Figure 14) and EL- 
ip  production (Figure 8C), even when used at low doses, and 2) unlike IL-4, IL-10 
does not block CD40-mediated rescue of monocytes from apoptosis (Figures 10, 11).
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We reported previously that neutralizing antibodies against IL-1 and TNF-a fail to 
block CD40-mediated rescue of monocytes from apoptosis (Suttles and others 1996), 
suggesting a lack of dependence on any autocrine effects of these cytokines in this 
process. Our current data further supports this observation by the fact that IL-10 
dramatically downregulates CD40-induced EL-ip synthesis, but does not block rescue 
from apoptosis.
An additional observation made during our research is that IL-4 and IL-10, 
either individually or in combination, have negligible downregulatory effects on CD40- 
mediated NF-kB activation (data not shown). This is an interesting observation since 
we have shown here that PTK activity is required for CD40-dependent EL-ip synthesis, 
and PTK inhibitors diminish NF-kB activation. There are several possibilities that may 
explain this occurrence. First, PTK inhibitors completely abrogated IL-ip synthesis, 
but only partially inhibited NF-kB activation. This suggests that other PTK-dependent 
transcription factors are involved in EL-ip synthesis, and these proteins may be the 
primary targets for the downregulatory actions of IL-4 and EL-10. Second, signaling 
events that lead to NF-kB activation, although dependent upon PTK activity, may be 
divergent from those that are influenced by IL-4 and IL-10. Third, although NF-kB 
may be critical to IL-ip gene transcription, signaling events that lead to NF-kB 
activation may lie upstream of the Erkl/Erk2 signaling cascade, the point in the CD40 
signaling pathway at which IL-4 and EL-10 exert their downregulatory effects (Figure 
16). It has been reported previously that NF-kB activity is required for the prevention 
o f factor-induced apoptosis in some cell types (Arsura and others 1996). Therefore,
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the fact that IL-10 does not block CD40-mediated rescue from apoptosis provides 
mechanistic support to the observation that IL-10 does not downregulate NF-kB 
activation, the maintenance of which may be vital to the rescue event.
The mechanisms through which IL-4 and IL-10 differentially influence CD40 
signal transduction in monocytes likely result from the use of distinct Jak kinases and 
ST AT transcription factors by these cytokines. While it has been elucidated which 
members of these families of signaling proteins are used by EL-4 and IL-10 when used 
individually, it is currently unknown whether treatment of monocytes with IL-4 and EL­
IO in combination results in the differential utilization of Jak-STAT proteins. As stated 
above, IL-4 signaling involves the activation of STAT6 by Jak3, and EL-10 signaling 
involves the activation of STAT1 and STAT3 by Jakl and/or Tyk2 (Figure 2). Pre­
treatment of monocytes with IL-10 resulted in the strong phosphorylation of STAT3 
(Figure 15). To a lesser degree, STAT3 was activated in monocytes treated with TmA 
alone (lane 2). It is possible that STAT3 activation by Tm!41 may eventually result in the 
establishment o f a negative feedback loop that downregulates TmNmediated pro- 
inflammatory cytokine synthesis over time, similar to the downregulatory effects 
induced by EL-10. Because the time period o f activation by Tm* alone (20 min) in this 
analysis was much shorter than that o f the time period of EL-10 treatment (18 h), high 
level STAT3 activation may not have occurred. As expected, IL-4 did not induce 
STAT3 activation. However, the slight activation of STAT3 that occurred with TmA 
stimulation alone was reduced in the IL-4 treated cells (lane 3). The reason for this is 
most likely not that EL-4 directly downregulates STAT3 activation, but that STAT3
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activation does not occur with TmA stimulation o f IL-4-treated cells because of the 
downregulatory effects of EL-4 on CD40 signaling. This hypothesis is further 
strengthened by the observation that STAT3 remained activated in monocytes pre­
treated with a combination of EL-4 and IL-10 (lane 5), in which the reduced level o f  
STAT3 activation observed compared to IL-10 treatment alone is probably a result of 
EL-10 being used at a reduced concentration. The establishment o f a negative feedback 
loop by CD40-mediated STAT3 activation would explain how EL-1 (3 induction by TmA 
may, like other known cellular responses, generally diminish over time. However, 
because resting monocytes are continually being recruited to the inflamed synovia of  
individuals with RA, where they are subsequently activated by Th cells, the 
establishment of a negative feedback loop in previously activated monocytes would 
likely not substantially reduce the overall inflammatory response.
It is also possible that the formation o f unique STAT heterodimers occurs in 
monocytes treated with a combination of EL-4 and EL-10 (Figure 2), which could 
explain their differential effects on CD40 signaling. To date, however, the existence of 
such heterodimers through cytokine signaling has not been determined.
Finally, recent studies have shown that direct cross-talk can occur between the 
MAPK and Jak-STAT signaling pathways during signal transduction, suggesting that 
signals transduced through one cascade may directly influence those of the other (David 
and others 1995; Winston and Hunter 1995). For example, signal transduction through 
the EFN-a/p receptor causes Erk2 and STAT1 to coimmunoprecipitate (David and 
others 1995). Such direct interactions between Erk and STAT proteins during CD40
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signaling in monocytes may also occur, and may provide a mechanism through which 
IL-4 and IL-10 exert their downregulatory effects on MAPK activity.
The use of IL-4 and IL-10 as therapeutic agents in the treatment o f autoimmune, 
cell-mediated inflammatory responses has been suggested based on the ability of these 
cytokines to redirect T cell responses from a Thl to Th2-like phenotype (Mosmann and 
Moore 1991; Sher and others 1991; Chatelain and others 1992; Maggi and others 1992; 
Sher and others 1992; Mocci and Coffman 1995). Our results suggest that these 
cytokines also selectively uncouple signaling pathways o f the T cell- 
monocyte/macrophage CD40L;CD40 interaction. During an active inflammatory 
response, the primary effects of IL-4 and IL-10 are likely to be due to their direct 
inhibition of monocyte/macrophage function. As the results herein show, the influence 
o f IL-4 and EL-10 occurred at the level of macrophage cytokine production. The fact 
that IL-4 and IL-10 synergize in EL-ip downregulation suggests that these cytokines 
could be used simultaneously at much lower doses than when used individually to exert 
sufficient anti-inflammatory effects. EL-4 has the additional ability to block CD40- 
mediated rescue of monocytes from apoptosis, and since EL-10 does not antagonize EL-4 
in this effect, the use of EL-4 and EL-10 together would not interfere with the ability of 
EL-4 to mediate the loss o f inflammatory monocytes at sites o f chronic, non-septic 
inflammation.
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